Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study

BACKGROUND: Current practices for assessing response to anti-interleukin 5/R treatment in severe asthma patients are heterogeneous. The objective of this study was to achieve an expert consensus defining failure criteria for anti-interleukin 5/R treatment in severe asthma patients. METHODS: Experts...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattei, Laura, Suehs, Carey M., Alagha, Khuder, Bourdin, Arnaud, Brousse, Christophe, Charriot, Jeremy, Devouassoux, Gilles, Fry, Stephanie, Guilleminault, Laurent, Gouitaa, Marion, Taille, Camille, Chanez, Pascal, Pahus, Laurie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504226/
https://www.ncbi.nlm.nih.gov/pubmed/34629000
http://dx.doi.org/10.1177/17534666211049735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504226/
https://www.ncbi.nlm.nih.gov/pubmed/34629000
http://dx.doi.org/10.1177/17534666211049735

Ejemplares similares